BrainCo Raises $280 Million for Non-Invasive BCI Push as China Backs Brain-Tech Expansion
Updated
Updated · CNBC · Jul 11
BrainCo Raises $280 Million for Non-Invasive BCI Push as China Backs Brain-Tech Expansion
1 articles · Updated · CNBC · Jul 11
Summary
$280 million in new funding gives BrainCo fresh capital to scale its non-invasive brain-computer interface business, with IDG Capital and Walden International co-leading the 2 billion yuan round.
BrainCo is betting easier-to-accept, lower-risk devices can reach more patients than implants, using proprietary dry-electrode sensors and AI decoding to read weak brain signals from outside the skull.
The Hangzhou startup already sells FDA-approved bionic hands and wearable devices, and says it will expand from amputees into conditions such as ADHD and depression before targeting consumer electronics.
Jefferies said conventional non-invasive BCI still faces signal-quality limits, but argued BrainCo's sensors, algorithms and commercialization record give it an edge as investors debate implants versus non-implanted approaches.
China is accelerating the sector through industrial policy, hospital partnerships and insurance support, turning BCI into a strategic field that could deepen U.S.-China tech rivalry as the market matures.
With China’s state-led BCI push, can America’s private ventures win the race to market?
Will brain-computer interfaces cure diseases, or create a new, enhanced class of human beings?
As devices begin reading our thoughts, who will own and protect our most private neural data?
BrainCo’s $280M Funding Signals China’s Push for Scaled Non-Invasive BCI: Global Race, Market Growth, and Ethical Frontiers
Overview
BrainCo, a leading brain-computer interface (BCI) company, has secured a major new round of financing totaling approximately 2 billion yuan ($280 million). This pivotal investment is strategically allocated to accelerate core BCI research and development, drive engineering breakthroughs, and scale product manufacturing towards mass production. The funding round attracted a diverse group of influential backers, including IDG, Walden International, Lens Technology, LY iTECH, and H World Group. This strong investor confidence signals a broader shift in the BCI industry from proof-of-concept projects to the development of scalable, market-ready products.